Healthy Male Subjects

Mass Balance Study of FYU-981

A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects

A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects

To Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects

Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects

ADME Study of [14C] Yiqibuvir in Healthy Male Subjects

Study of RPT193 in Healthy Adult Male Subjects

A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects

Bioequivalence Study of Tafolecimab Injections in Chinese Healthy Male Volunteers

ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects

A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects

AVT03 With Prolia in Healthy Male Subjects

Phase I Study of Sintilimab in Healthy Chinese Male Subjects

Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers

Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects

Mass Balance Study of [14C] TAS-205 in Healthy Volunteers

Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects

A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects

Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356

A Human AME Study for Omaveloxolone

Single Dose Study With Unlabeled Dose and 14C-labeled Microdose of PF-06700841 in Healthy Male Subjects

Study to Investigate the Pharmacokinetic Profile

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects

Mass Balance and Metabolism Study of 14C-Z-215

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects

Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male Volunteers After Single and Multiple-dose Subcutaneous Administration of the Test Injectable Formulation BK0023 vs. Neupogen®